Does Takeda Pharmaceutical (TAK) Pay a Dividend? (2026)
Last updated July 2026
Short answer
Takeda Pharmaceutical (TAK) pays a dividend with an approximate yield of ~3.7% as of early 2026, typically quarterly. A dividend is a slice of profits returned to shareholders, and the yield is that payout divided by the share price, so it drifts as both change. Figures here are approximate; verify the current number with your broker.
Does Takeda Pharmaceutical (TAK) pay a dividend?
Yes. Takeda Pharmaceutical distributes an approximate ~3.7% yield (early 2026), usually quarterly. Takeda's fiscal 2025 (ended March 2026) revenue slipped modestly as Vyvanse generic erosion outweighed newer growth products, while core operating profit held roughly flat thanks to cost savings. The low forward earnings multiple and mid-single-digit dividend yield reflect a market pricing in slow growth and patent-cliff risk rather than expansion. Statutory (GAAP-style) earnings have been noisy because of amortization and impairments tied to past acquisitions, so investors often focus on the company's core (adjusted) profit measures.
TAK dividend at a glance
| 2025-03-31 | $0.339 |
| 2024-09-30 | $0.326 |
| 2024-03-27 | $0.292 |
TAK dividend data as of July 2026, sourced from Yahoo Finance and may be delayed. Yield moves with price and payout; confirm the current dividend and ex-date with TAK's investor relations page before relying on it.
How to think about TAK's dividend
- Yield is a snapshot: ~3.7% today, but it moves with price and payout.
- Total return vs income: dividends are one part of return; price change is usually the bigger part for a name like TAK.
- Reinvest or take income: a DRIP compounds; taking the cash gives income now.
- For more yield: dedicated dividend stocks and ETFs target higher payouts. See the best dividend ETFs.
The bottom line on the TAK dividend
Takeda Pharmaceutical (TAK) pays an approximate ~3.7% dividend, so it offers some income but is held mostly for total return, not yield. For the full picture see the TAK guide. Walnut can show how TAK fits your real portfolio. It is not an investment adviser.
Build a basket around TAK with Walnut
Use Takeda Pharmaceutical as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Does Takeda Pharmaceutical (TAK) pay a dividend?
+
Takeda Pharmaceutical has an approximate dividend yield of ~3.7% (early 2026). Yields move with price and payout, so treat this as a recent snapshot and verify the current figure with your broker or TAK's investor relations page.
What is TAK's dividend yield?
+
Approximately ~3.7% as of early 2026 (approximate, verify). Remember a higher yield is not automatically better: it can reflect a falling share price as much as a generous payout.
How often does TAK pay its dividend?
+
US companies that pay dividends, like Takeda Pharmaceutical if it does, typically distribute them quarterly. Confirm the exact schedule and ex-dividend dates on TAK's investor relations page before relying on the timing.
Can I reinvest TAK dividends?
+
Yes. Most brokers offer automatic dividend reinvestment (a DRIP) so any TAK dividend buys more shares automatically. It compounds over time but is still taxable in a taxable account.
Is TAK a good dividend stock?
+
Walnut is informational, not investment advice. With an approximate ~3.7% yield, TAK is more of an income name. Dedicated dividend stocks and ETFs target higher, steadier yield; match the choice to whether you want income now or growth.
Does TAK pay a dividend?
+
Yes. Takeda pays a semiannual dividend that translates to a yield of roughly 3.7 percent on the ADR as of mid-2026. Because earnings are yen-denominated, the dollar value US holders receive can vary with the yen exchange rate.
Walnut is informational, not investment advice. Dividend figures are approximate and dated; verify current yield, schedule, and policy with TAK's investor relations page or your broker.